Recurrence of Focal-Segmental Glomerulosclerosis in Children after Renal Transplantation: Clinical and Genetic Aspects
- 27 September 2005
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 80 (1S), S128-S134
- https://doi.org/10.1097/01.tp.0000187110.25512.82
Abstract
Focal segmental glomerulosclerosis (FSGS) is the primary renal disease in approximately one-tenth of pediatric patients receiving a renal allograft. Recurrence of proteinuria after renal transplantation is observed in approximately 30% of patients and negatively impacts graft survival. Risk factors for recurrence are a chronological age <15 years at onset of the nephrotic syndrome and a rapid progression of the disease in the native kidneys leading to end-stage renal disease in less than 3 years. Mesangial proliferation in the native kidneys is also an important negative predictive factor for disease recurrence. With rapid recurrence of FSGS and loss of the allograft, further renal transplants also carry a high likelihood of FSGS recurrence. Different pathogenic factors have been discussed for the recurrence of proteinuria/FSGS in the transplanted kidney, especially the involvement of a proteinuric circulating factor, whose production seems to follow T-cell dysfunction. In the last decade, mutations in genes encoding podocyte proteins have been identified in different forms of hereditary FSGS. Mutations of NPHS2 were detected in 26-38% of familial autosomal recessive steroid-resistant NS (SRNS), 6-19% of sporadic cases of SRNS, and in few adult patients with FSGS. Large multicenter studies demonstrated that patients with two pathogenic NPHS2 mutations have a very low risk of recurring FSGS after renal transplantation, whereas patients with only one mutation presumably have a risk comparable to non-NPHS2 FSGS patients. The management of FSGS following renal transplantation remains controversial. Following the assumption of a putative permeability factor, several studies have suggested the efficacy of plasmapheresis in inducing remission, preferably in conjunction with high-dose cyclosporine A or cyclophosphamide. Prospective studies will be necessary to better evaluate different therapeutic approaches.Keywords
This publication has 55 references indexed in Scilit:
- NPHS2 mutation associated with recurrence of proteinuria after transplantationPediatric Nephrology, 2004
- Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic SyndromeJournal of the American Society of Nephrology, 2004
- Early use of plasmapheresis for recurrent post-transplant FSGSPediatric Nephrology, 2003
- Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantationPediatric Nephrology, 2002
- Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in childrenAmerican Journal of Kidney Diseases, 1999
- THE INFLUENCE OF NATIVE NEPHRECTOMY ON THE INCIDENCE OF RECURRENT DISEASE FOLLOWING RENAL TRANSPLANTATION FOR PRIMARY GLOMERULONEPHRITIS1Transplantation, 1996
- INCIDENCE, TREATMENT, AND OUTCOME OF RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS POSTTRANSPLANTATION IN 42 ALLOGRAFTS IN CHILDRENTransplantation, 1991
- THE RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN KIDNEY TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINETransplantation, 1990
- Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: Analysis of incidence and risk factors in 59 allograftsPediatric Nephrology, 1990
- RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN RENAL ALLOGRAFTSTransplantation, 1981